Liberty Gold (TSE:LGD) Given a C$0.90 Price Target at National Bank Financial

Share on StockTwits

Liberty Gold (TSE:LGD) has been assigned a C$0.90 price objective by research analysts at National Bank Financial in a report issued on Tuesday, BayStreet.CA reports. The brokerage presently has an “outperform” rating on the stock. National Bank Financial’s price target suggests a potential upside of 52.54% from the stock’s current price.

TSE LGD traded up C$0.01 during trading hours on Tuesday, reaching C$0.59. The company had a trading volume of 124,501 shares, compared to its average volume of 215,496. The stock has a 50-day moving average of C$0.61 and a 200 day moving average of C$0.44. Liberty Gold has a 1-year low of C$0.29 and a 1-year high of C$0.71. The company has a current ratio of 8.18, a quick ratio of 8.02 and a debt-to-equity ratio of 2.18. The stock has a market capitalization of $120.44 million and a P/E ratio of -11.13.

About Liberty Gold

Liberty Gold Corp., a gold discovery company, engages in the acquisition, exploration, and development of mineral properties primarily in the United States and Turkey. It explores for gold, silver, and copper ores. The company's flagship projects include Goldstrike, Black Pine, and Kinsley Mountain projects located in the Great Basin of the United States.

See Also: Day Trading

Receive News & Ratings for Liberty Gold Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Gold and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Gateley Holdings PLC  to Distribute Dividend of GBX 5.40 on  October 16th
Gateley Holdings PLC to Distribute Dividend of GBX 5.40 on October 16th
Equiniti Group PLC Plans Dividend of GBX 1.95
Equiniti Group PLC Plans Dividend of GBX 1.95
Armada Hoffler Properties  & Nam Tai Property  Head-To-Head Review
Armada Hoffler Properties & Nam Tai Property Head-To-Head Review
Critical Comparison: Taro Pharmaceutical Industries  and Genmab A/S
Critical Comparison: Taro Pharmaceutical Industries and Genmab A/S
Critical Comparison: Jerash Holdings   versus Its Rivals
Critical Comparison: Jerash Holdings versus Its Rivals
Comparing Symantec  & Tyler Technologies
Comparing Symantec & Tyler Technologies


 
© 2006-2019 Zolmax.